A key building block in the Schmallenberg virus could be targeted by anti-viral drugs, according to a new study led from the University of Leeds.
The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the recommended course of treatment for some women.
Drug discovery relies on a huge range of techniques, from polymerase chain reaction analysis to clinical trial design. Here we highlight the latest innovations designed to cut costs and increase the speed of new drug discovery
Patients suffering from high blood pressure - the single most important risk for death worldwide - could be helped by a UK-wide clinical trial aimed at improving treatments.
BioEquity is the top European event for life science investors showcasing companies on the forefront of innovation.
The Start-up company will develop therapeutic antibodies against novel targets in the fields of cancer and inflammation.
Patients to benefit from potential for improved efficacy in less commonly used types of antiretroviral therapies and one-pill-daily combination drugs
Technology licensing tie-ups and more targeted discovery solutions are driving new drug developments
Researchers at Queen’s University Belfast have devised a ‘magic bullet’ nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive care.
Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients aged 2 years and older.
Oxford Gene Technology marks World Lupus Day with announcement of novel biomarker panel to support earlier SLE diagnosis
New data presented at EMCTO showed that first-line therapy with gefitinib (IRESSATM) in Caucasian patients with EGFR mutation-positive advanced NSCLC resulted in an ORR of 70% (95% CI 61-78)
A Wayne State University researcher has successfully tested a technique that can lead to more effective use of nanoparticles as a drug delivery system.
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from the University of Toronto and Manchester University.
A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.
UK regenerative medicine platform (UKRMP) safety hub announced